Matulionis D H, Kimmel E, Diamond L
Environ Res. 1985 Apr;36(2):298-313. doi: 10.1016/0013-9351(85)90026-x.
The combined effects of cigarette smoke inhalation and hydrocortisone acetate (HCA) treatment induce prominent abnormalities in lungs of C57BL/6 male mice. These abnormalities include (1) a marked reduction of pulmonary macrophage population which is normally elevated by smoke inhalation, (2) an accumulation of surfactant and flocculent material in alveoli, (3) a decrease in alveolar space surrounded by normal septal tissue, and (4) an increase in hypertrophied alveolar parenchyma. Concomitant with altered lung morphology, lung volume and gas diffusing capacity were significantly compromised in animals subjected to smoke exposure and steroid treatment. It was found that smoke inhalation or HCA administration alone had no ill effects on the animals. The data presented indicate that manifestation of pathologic conditions resembling pulmonary fibrosis and pulmonary alveolar proteinosis is a result of cigarette smoke-drug interaction. The information reported provides a basis for an animal model which might be applicable to assessment of factors related to smoke inhalation and development of pulmonary disorders.
吸入香烟烟雾和醋酸氢化可的松(HCA)治疗的联合作用在C57BL/6雄性小鼠肺部诱发了显著异常。这些异常包括:(1)肺部巨噬细胞数量显著减少,而正常情况下吸入烟雾会使其数量增加;(2)肺泡中表面活性剂和絮状物质积聚;(3)正常间隔组织所包围的肺泡空间减小;(4)肺泡实质肥大增加。与肺部形态改变相伴的是,暴露于烟雾和接受类固醇治疗的动物的肺容积和气体扩散能力显著受损。研究发现,单独吸入烟雾或给予HCA对动物没有不良影响。所呈现的数据表明,类似肺纤维化和肺泡蛋白沉积症的病理状况的表现是香烟烟雾与药物相互作用的结果。所报告的信息为一种动物模型提供了基础,该模型可能适用于评估与吸入烟雾及肺部疾病发展相关的因素。